RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-5432
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1108000; Gene model (P.falciparum): PF3D7_0508400; Gene product: CFA20 domain-containing protein, putative (FAP20)
Transgene
Transgene not Plasmodium: RFP
Promoter: Gene model: PBANKA_1319500; Gene model (P.falciparum): PF3D7_1455800; Gene product: LCCL domain-containing protein (LAP4; LCCL/lectin adhesive-like protein 4; CCp2)
3'UTR: Gene model: PBANKA_1359600; Gene product: transmission blocking target antigen precursor 6-cysteine protein (P48/45)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Transgene
Transgene not Plasmodium: GFP (gfp-mut3)
Promoter: Gene model: PBANKA_0416100; Gene model (P.falciparum): PF3D7_0905300; Gene product: dynein heavy chain, putative
3'UTR: Gene model: PBANKA_1010600; Gene product: calmodulin, putative (cam)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (P230p; 230p)
PhenotypeNo phenotype has been described
Last modified: 28 March 2024, 11:49
  *RMgm-5432
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 820cl1m1cl1 (RMgm-164)
Other information parent lineP. berghei ANKA 820cl1m1cl1 (RMgm-164) is a reference ANKA mutant line which expresses GFP under control of a male and RFP under control of a female gametocyte specific promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 19438517).
The mutant parasite was generated by
Name PI/ResearcherHentzschel F, Frischknecht F
Name Group/DepartmentHeidelberg University Medical Faculty, University Hospital Heidelberg
Name InstituteCenter for Infectious Diseases
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-5432
Principal nameFAP20(-)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of FAP20. In addition, it expresses GFP under control of a male gametocyte specific promoter and RFP under the control of a female gametocyte specific' promoter (and the mutant does not contain a drug-selectable marker cassette that has been removed by negative selection).

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2023.10.19.562943

Protein (function)
Male gametocytes undergo three rounds of rapid genome replication via closed mitosis and coordinate the formation of eight axonemes with genome multiplication and separation. From a bipartite microtubule organizing center (MTOC) that bridges the nuclear envelope, mitotic spindles form within the nucleus, and axonemes form at the cytosolic face of the MTOC. Plasmodium axonemes usually feature a classic 9+2 microtubule array with two central microtubules being surrounded by 9 doublets. Yet, often axonemes with deviating arrays are formed. Parasites that cannot form axonemes or form non-motile axonemes are infertile and cannot establish an infection in the mosquito. Whether Plasmodium axoneme assembly, stability or function depends on Microtubule inner proteins (MIPs) has not been studied so far.
Microtubule inner proteins, MIPs, are microtubule associated proteins that bind to tubulin from the luminal side. Most MIPs so far were found in axonemes with over 60 MIPs being revealed in sperm axonemes. To investigate if there are MIPs in Plasmodium axonemes we searched for orthologs to known MIPs from other organisms using PlasmoDB. Blasting known axoneme associated MIPs), we identified orthologues to the two flagellar associated proteins FAP20 and FAP52. P. berghei and P. falciparum FAP52 orthologues were less well preserved (compared to FAP20 on a sequence level), but their structure, consisting of two WD40 domains, was highly similar to that of human or Chlamydomonas FAP52.

Phenotype
No phenotype different from wild type was detected throughout the complete life cycle (although a (slightly) lower number of salivary gland sporozoites compared to wildtype).

See also mutant RMgm-5434 (fab20/fap52(-)) lacking expression of both FAP20 and FAB52: this mutant showed strongly reduced male gamete formation (and ookinete/oocyst formation). Evidence is presented that axonemes are formed during male gamete formation of mutant
fab20/fap52(-) but that in the microtubule doublets often a small gap exists between the protofilaments that link the B-tubule to the A-tubule

Additional information
 From the paper: 'Microtubule inner proteins, MIPs, are microtubule associated proteins that bind to tubulin from the luminal side. Here we investigate the role of four MIPs in a rodent malaria parasite for their role in transmission to and from the mosquito. We show by single and double gene deletions that SPM1 and TrxL1, MIPs associated with the subpellicular microtubules are dispensable for transmission from the vertebrate host to the mosquito and back. In contrast, FAP20 and FAP52, MIPs associated with the axonemes of gametes, are essential for transmission to mosquitoes but only if both genes are deleted. In the absence of both, FAP20 and FAP52 the B-tubule of the axoneme partly detaches from the A-tubule resulting in the deficiency of axonemal beating and hence gamete formation and egress. Our data suggest that a high level of redundancy ensures microtubule stability in the transmissive stages of Plasmodium'.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1108000
Gene Model P. falciparum ortholog PF3D7_0508400
Gene productCFA20 domain-containing protein, putative
Gene product: Alternative nameFAP20
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedYes
Name of PlasmoGEM construct/vector-
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modificationFor gene deletion of PbSPM1 (PBANKA_0810700), PbTrxL1 (PBANKA_0820200), PbFAP20 (PBANKA_1108000) and PbFAP52 (PBANKA_1361500), the respective transfection vectors were obtained from PlasmoGEM. Prior to transfection, 3-5 µg of each vector were linearized using NotI followed by ethanol precipitation.
The linearized vectors were transfected into the parental P. berghei strain (PbANKA wildtype for SPM1 and TrxL1, and Pb820 wildtype for FAP20 and FAP52).
In order to be able to reuse pyrimethamine as a selective (positive) pressure in subsequent mutant generations, 5-fluorocytosine (5-FC) selection (negative) was performed. Here, trxL1(-) and fap20(-) parasites that recycled the selection cassette were negatively selected for via 5-FC (1 mg/ml) administered via the mice’s drinking water and isogenic clones were isolated by limited dilution and verified via genotyping PCR accordingly. After obtaining marker-free clones, the second knockout (spm1 or fap52) was generated in these lines.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameRFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1319500
Gene Model P. falciparum ortholog PF3D7_1455800
Gene productLCCL domain-containing protein
Gene product: Alternative nameLAP4; LCCL/lectin adhesive-like protein 4; CCp2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1359600
Gene producttransmission blocking target antigen precursor 6-cysteine protein
Gene product: Alternative nameP48/45
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mut3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0416100
Gene Model P. falciparum ortholog PF3D7_0905300
Gene productdynein heavy chain, putative
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1010600
Gene productcalmodulin, putative
Gene product: Alternative namecam
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative nameP230p; 230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4